EP 1094806 A2 20010502 - VASCULOPROTECTOR
Title (en)
VASCULOPROTECTOR
Title (de)
SCHUTZMITTEL DER VASCULATUR
Title (fr)
VASCULOPROTECTEUR
Publication
Application
Priority
- GB 9902157 W 19990706
- GB 9814620 A 19980706
Abstract (en)
[origin: WO0001716A2] The invention relates to a method of inducing a vasculoprotective effect in a subject, the method comprising treating the subject with an ER beta agonist.
[origin: WO0001716A2] The invention relates to a method of inducing a vasculoprotective effect, particularly relating to restonosis, angioplasty, chronic allograft rejection, diabetic angiopathy, autoimmune angiopathy, ateriosclerosis and atherosclerosis in a subject, the method comprising treating the subject with an ERbeta agonist. The preferred Estrogen Receptor beta agonist is genistein.
IPC 1-7
IPC 8 full level
A61K 31/352 (2006.01); A61K 31/439 (2006.01); A61K 45/00 (2006.01); A61P 9/00 (2006.01); A61P 9/10 (2006.01); A61P 37/06 (2006.01); C07D 471/22 (2006.01); C12N 5/10 (2006.01)
CPC (source: EP KR)
A61K 31/35 (2013.01 - KR); A61K 31/352 (2013.01 - EP); A61P 9/00 (2017.12 - EP); A61P 9/10 (2017.12 - EP); A61P 37/06 (2017.12 - EP)
Citation (search report)
See references of WO 0001716A2
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
DOCDB simple family (publication)
WO 0001716 A2 20000113; WO 0001716 A3 20001005; AU 4636499 A 20000124; CA 2331885 A1 20000113; EP 1094806 A2 20010502; GB 9814620 D0 19980902; JP 2002519435 A 20020702; KR 20010079495 A 20010822
DOCDB simple family (application)
GB 9902157 W 19990706; AU 4636499 A 19990706; CA 2331885 A 19990706; EP 99929579 A 19990706; GB 9814620 A 19980706; JP 2000558117 A 19990706; KR 20017000141 A 20010105